Indicaciones y manejo de la toxina botulinica

Translated title of the contribution: Indications and use of botulinus toxin

Research output: Contribution to journalArticle

Abstract

Botulinus toxin (BTX) is the most potent biological toxin yet known. It is produced by Clostridium botulinium, a Gram positive bacteria. Type A Botulinus toxin is the most widely used in human drug trials. It has become the treatment of choice for blepharospasm, hemifacial spasm, cervical dystonia and laryngeal dystonia. It may also be used in the treatment of patients with oromandibular dystonia and limb dystonia, especially writer's cramp, and has been used successfully in the treatment of spasticity and cerebral paralysis. There are many benefits from this treatment, including improved walking, improved posture of wheelchair patients, improvement of patients with spasms and easier extension of their arms and knees. The toxin also alleviates pain and may be used in therapeutic trials for prediction of the response to surgical elongation.

Original languageSpanish
Pages (from-to)16-22
Number of pages7
JournalRevista Ecuatoriana de Neurologia
Volume9
Issue number1-2
StatePublished - Jan 1 2000

Fingerprint

Dystonia
Biological Toxins
Blepharospasm
Hemifacial Spasm
Dystonic Disorders
Therapeutics
Torticollis
Wheelchairs
Clostridium
Spasm
Gram-Positive Bacteria
Posture
Paralysis
Walking
Knee
Arm
Pain
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Indicaciones y manejo de la toxina botulinica. / Singer, Carlos.

In: Revista Ecuatoriana de Neurologia, Vol. 9, No. 1-2, 01.01.2000, p. 16-22.

Research output: Contribution to journalArticle

@article{b72c8c64e96643f2abb857cb7d518264,
title = "Indicaciones y manejo de la toxina botulinica",
abstract = "Botulinus toxin (BTX) is the most potent biological toxin yet known. It is produced by Clostridium botulinium, a Gram positive bacteria. Type A Botulinus toxin is the most widely used in human drug trials. It has become the treatment of choice for blepharospasm, hemifacial spasm, cervical dystonia and laryngeal dystonia. It may also be used in the treatment of patients with oromandibular dystonia and limb dystonia, especially writer's cramp, and has been used successfully in the treatment of spasticity and cerebral paralysis. There are many benefits from this treatment, including improved walking, improved posture of wheelchair patients, improvement of patients with spasms and easier extension of their arms and knees. The toxin also alleviates pain and may be used in therapeutic trials for prediction of the response to surgical elongation.",
author = "Carlos Singer",
year = "2000",
month = "1",
day = "1",
language = "Spanish",
volume = "9",
pages = "16--22",
journal = "Revista Ecuatoriana de Neurologia",
issn = "1019-8113",
publisher = "Fundacion para la difusion neurologica en Ecuador - FUNDINE",
number = "1-2",

}

TY - JOUR

T1 - Indicaciones y manejo de la toxina botulinica

AU - Singer, Carlos

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Botulinus toxin (BTX) is the most potent biological toxin yet known. It is produced by Clostridium botulinium, a Gram positive bacteria. Type A Botulinus toxin is the most widely used in human drug trials. It has become the treatment of choice for blepharospasm, hemifacial spasm, cervical dystonia and laryngeal dystonia. It may also be used in the treatment of patients with oromandibular dystonia and limb dystonia, especially writer's cramp, and has been used successfully in the treatment of spasticity and cerebral paralysis. There are many benefits from this treatment, including improved walking, improved posture of wheelchair patients, improvement of patients with spasms and easier extension of their arms and knees. The toxin also alleviates pain and may be used in therapeutic trials for prediction of the response to surgical elongation.

AB - Botulinus toxin (BTX) is the most potent biological toxin yet known. It is produced by Clostridium botulinium, a Gram positive bacteria. Type A Botulinus toxin is the most widely used in human drug trials. It has become the treatment of choice for blepharospasm, hemifacial spasm, cervical dystonia and laryngeal dystonia. It may also be used in the treatment of patients with oromandibular dystonia and limb dystonia, especially writer's cramp, and has been used successfully in the treatment of spasticity and cerebral paralysis. There are many benefits from this treatment, including improved walking, improved posture of wheelchair patients, improvement of patients with spasms and easier extension of their arms and knees. The toxin also alleviates pain and may be used in therapeutic trials for prediction of the response to surgical elongation.

UR - http://www.scopus.com/inward/record.url?scp=0033867422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033867422&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033867422

VL - 9

SP - 16

EP - 22

JO - Revista Ecuatoriana de Neurologia

JF - Revista Ecuatoriana de Neurologia

SN - 1019-8113

IS - 1-2

ER -